Titre : Épistaxis

Épistaxis : Questions médicales fréquentes

Termes MeSH sélectionnés :

Clinical Trials Data Monitoring Committees
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Épistaxis : Questions médicales les plus fréquentes", "headline": "Épistaxis : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Épistaxis : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-01", "dateModified": "2025-02-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Épistaxis" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Signes et symptômes respiratoires", "url": "https://questionsmedicales.fr/mesh/D012818", "about": { "@type": "MedicalCondition", "name": "Signes et symptômes respiratoires", "code": { "@type": "MedicalCode", "code": "D012818", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.888.852" } } }, "about": { "@type": "MedicalCondition", "name": "Épistaxis", "alternateName": "Epistaxis", "code": { "@type": "MedicalCode", "code": "D004844", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "None None", "url": "https://questionsmedicales.fr/author/None%20None", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "David E Tunkel", "url": "https://questionsmedicales.fr/author/David%20E%20Tunkel", "affiliation": { "@type": "Organization", "name": "Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA." } }, { "@type": "Person", "name": "Sarah M Holdsworth", "url": "https://questionsmedicales.fr/author/Sarah%20M%20Holdsworth", "affiliation": { "@type": "Organization", "name": "Emory University Hospital, Atlanta, Georgia, USA." } }, { "@type": "Person", "name": "Jacqueline D Alikhaani", "url": "https://questionsmedicales.fr/author/Jacqueline%20D%20Alikhaani", "affiliation": { "@type": "Organization", "name": "Consumers United for Evidence-based Healthcare (CUE), Baltimore, Maryland, USA." } }, { "@type": "Person", "name": "Taskin M Monjur", "url": "https://questionsmedicales.fr/author/Taskin%20M%20Monjur", "affiliation": { "@type": "Organization", "name": "American Academy of Otolaryngology-Head and Neck Surgery Foundation, Alexandria, Virginia, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.", "datePublished": "2023-03-06", "url": "https://questionsmedicales.fr/article/36700391", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/dom.14989" } }, { "@type": "ScholarlyArticle", "name": "Estimation and feasibility of correction modelling for mother-reported child height and weight at 2 years using data from the Australian CHAT trial.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36494386", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-25388-8" } }, { "@type": "ScholarlyArticle", "name": "Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).", "datePublished": "2024-02-13", "url": "https://questionsmedicales.fr/article/38350888", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12885-024-11899-2" } }, { "@type": "ScholarlyArticle", "name": "Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).", "datePublished": "2023-12-23", "url": "https://questionsmedicales.fr/article/38196590", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.21203/rs.3.rs-3773522/v1" } }, { "@type": "ScholarlyArticle", "name": "Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry.", "datePublished": "2024-06-20", "url": "https://questionsmedicales.fr/article/38899459", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1161/CIRCOUTCOMES.123.010614" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Signes et symptômes", "item": "https://questionsmedicales.fr/mesh/D012816" }, { "@type": "ListItem", "position": 4, "name": "Signes et symptômes respiratoires", "item": "https://questionsmedicales.fr/mesh/D012818" }, { "@type": "ListItem", "position": 5, "name": "Épistaxis", "item": "https://questionsmedicales.fr/mesh/D004844" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Épistaxis - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Épistaxis", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-16", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Épistaxis", "description": "Comment diagnostiquer une épistaxis ?\nQuels tests sont nécessaires pour l'épistaxis ?\nQuand consulter un spécialiste pour épistaxis ?\nQuels signes indiquent une épistaxis grave ?\nL'imagerie est-elle nécessaire pour l'épistaxis ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Clinical+Trials+Data+Monitoring+Committees&page=996#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Épistaxis", "description": "Quels sont les symptômes de l'épistaxis ?\nL'épistaxis peut-elle causer des douleurs ?\nPeut-on avoir des saignements bilatéraux ?\nY a-t-il des signes d'infection avec l'épistaxis ?\nL'épistaxis peut-elle être chronique ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Clinical+Trials+Data+Monitoring+Committees&page=996#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Épistaxis", "description": "Comment prévenir l'épistaxis ?\nLes allergies peuvent-elles causer l'épistaxis ?\nFaut-il éviter de se moucher fort ?\nLes médicaments anticoagulants augmentent-ils le risque ?\nComment maintenir l'humidité nasale ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Clinical+Trials+Data+Monitoring+Committees&page=996#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Épistaxis", "description": "Comment traiter une épistaxis légère ?\nQuels médicaments peuvent aider l'épistaxis ?\nQuand utiliser un cautérisateur pour l'épistaxis ?\nLes antibiotiques sont-ils nécessaires pour l'épistaxis ?\nQuelles interventions chirurgicales existent pour l'épistaxis ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Clinical+Trials+Data+Monitoring+Committees&page=996#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Épistaxis", "description": "Quelles complications peuvent survenir avec l'épistaxis ?\nL'épistaxis peut-elle entraîner une perte de sang importante ?\nPeut-on avoir des séquelles après une épistaxis ?\nL'épistaxis peut-elle causer des infections ?\nQuels sont les risques d'une épistaxis chronique ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Clinical+Trials+Data+Monitoring+Committees&page=996#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Épistaxis", "description": "Quels sont les facteurs de risque de l'épistaxis ?\nLe tabagisme augmente-t-il le risque d'épistaxis ?\nLes traumatismes nasaux sont-ils un facteur de risque ?\nLes infections respiratoires peuvent-elles causer l'épistaxis ?\nL'hypertension est-elle un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D004844?mesh_terms=Clinical+Trials+Data+Monitoring+Committees&page=996#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une épistaxis ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'examen physique et l'historique médical du patient." } }, { "@type": "Question", "name": "Quels tests sont nécessaires pour l'épistaxis ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins peuvent être effectués pour évaluer la coagulation sanguine." } }, { "@type": "Question", "name": "Quand consulter un spécialiste pour épistaxis ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un ORL si les saignements sont fréquents ou sévères." } }, { "@type": "Question", "name": "Quels signes indiquent une épistaxis grave ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des saignements abondants, des vertiges ou une perte de conscience nécessitent une attention immédiate." } }, { "@type": "Question", "name": "L'imagerie est-elle nécessaire pour l'épistaxis ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie est rarement nécessaire, sauf en cas de suspicion de lésion sous-jacente." } }, { "@type": "Question", "name": "Quels sont les symptômes de l'épistaxis ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent un saignement nasal, parfois accompagné de douleur ou de congestion." } }, { "@type": "Question", "name": "L'épistaxis peut-elle causer des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épistaxis peut être accompagnée de douleurs au nez ou de sensations de pression." } }, { "@type": "Question", "name": "Peut-on avoir des saignements bilatéraux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épistaxis peut survenir dans une ou les deux narines, selon la cause." } }, { "@type": "Question", "name": "Y a-t-il des signes d'infection avec l'épistaxis ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des signes d'infection peuvent inclure des écoulements purulents ou de la fièvre." } }, { "@type": "Question", "name": "L'épistaxis peut-elle être chronique ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines personnes peuvent souffrir d'épistaxis récurrente ou chronique." } }, { "@type": "Question", "name": "Comment prévenir l'épistaxis ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les irritants nasaux, hydratez-vous et utilisez un humidificateur d'air." } }, { "@type": "Question", "name": "Les allergies peuvent-elles causer l'épistaxis ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les allergies peuvent provoquer une inflammation et des saignements du nez." } }, { "@type": "Question", "name": "Faut-il éviter de se moucher fort ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, se moucher trop fort peut provoquer ou aggraver une épistaxis." } }, { "@type": "Question", "name": "Les médicaments anticoagulants augmentent-ils le risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les anticoagulants peuvent augmenter le risque d'épistaxis en affectant la coagulation." } }, { "@type": "Question", "name": "Comment maintenir l'humidité nasale ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des sprays salins ou des gels pour garder les muqueuses nasales hydratées." } }, { "@type": "Question", "name": "Comment traiter une épistaxis légère ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Pour une épistaxis légère, il est conseillé de se pencher en avant et de pincer le nez." } }, { "@type": "Question", "name": "Quels médicaments peuvent aider l'épistaxis ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des décongestionnants ou des sprays nasaux peuvent être utilisés pour réduire l'inflammation." } }, { "@type": "Question", "name": "Quand utiliser un cautérisateur pour l'épistaxis ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Un cautérisateur est utilisé pour sceller les vaisseaux sanguins en cas de saignements persistants." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils nécessaires pour l'épistaxis ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les antibiotiques ne sont pas généralement nécessaires, sauf en cas d'infection associée." } }, { "@type": "Question", "name": "Quelles interventions chirurgicales existent pour l'épistaxis ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des interventions comme l'embolisation des vaisseaux peuvent être nécessaires pour les cas graves." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'épistaxis ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'anémie, l'infection ou des problèmes respiratoires graves." } }, { "@type": "Question", "name": "L'épistaxis peut-elle entraîner une perte de sang importante ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une épistaxis sévère peut entraîner une perte de sang significative et nécessiter une intervention." } }, { "@type": "Question", "name": "Peut-on avoir des séquelles après une épistaxis ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des séquelles sont rares, mais des problèmes de coagulation peuvent persister." } }, { "@type": "Question", "name": "L'épistaxis peut-elle causer des infections ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections peuvent survenir si des bactéries pénètrent par les muqueuses endommagées." } }, { "@type": "Question", "name": "Quels sont les risques d'une épistaxis chronique ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "L'épistaxis chronique peut entraîner des complications comme l'anémie ou des troubles de la coagulation." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'épistaxis ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent la sécheresse de l'air, les allergies, et l'utilisation de médicaments anticoagulants." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque d'épistaxis ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut irriter les muqueuses nasales et augmenter le risque de saignement." } }, { "@type": "Question", "name": "Les traumatismes nasaux sont-ils un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes au nez, comme les coups ou les chutes, augmentent le risque d'épistaxis." } }, { "@type": "Question", "name": "Les infections respiratoires peuvent-elles causer l'épistaxis ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les infections respiratoires peuvent provoquer une inflammation et des saignements du nez." } }, { "@type": "Question", "name": "L'hypertension est-elle un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'hypertension peut augmenter le risque d'épistaxis en exerçant une pression sur les vaisseaux sanguins." } } ] } ] }

Sources (10000 au total)

Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes.

To apply the diabetes staging system (DSS), a novel disease staging system similar to what is used in oncology but designed to improve diabetes management, to three large type 2 diabetes (T2D) cardiov... The DSS uses discrete CV events (none to ≥3: Stage 1 to 4), end-stage kidney disease (Stage 5) and microvascular complications (none to 3: A to D) to determine disease stage in individuals with T2D. T... The risk of ACM or CV death increased with increasing DSS (Stage 1 to 5; P for trend <0.0001) in all trials. In CAROLINA, the risk of ACM and CV death increased with increasing number of microvascular... Applying the DSS across T2D clinical trial populations with different CV risk revealed a significantly increased risk of ACM and CV death with higher DSS stage. The DSS may merit assessment in other T...

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).

For patients with liver-confined metastatic colorectal cancer (mCRC), local therapy of isolated metastases has been associated with long-term progression-free and overall survival (OS). However, for p... The Evaluating Radiation, Ablation, and Surgery (ERASur) A022101/NRG-GI009 trial is a randomized, National Cancer Institute-sponsored phase III study evaluating if the addition of metastatic-directed ... The ERASur trial employs a pragmatic interventional design to test the efficacy and safety of adding multimodality TAT to standard of care systemic therapy in patients with limited mCRC.... ClinicalTrials.gov: NCT05673148, registered December 21, 2022....

Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur).

For patients with liver-confined metastatic colorectal cancer (mCRC), local therapy of isolated metastases has been associated with long-term progression-free and overall survival (OS). However, for p... The Evaluating Radiation, Ablation, and Surgery (ERASur) A022101/NRG-GI009 trial is a randomized, National Cancer Institute-sponsored phase III study evaluating if the addition of metastatic-directed ... The ERASur trial employs a pragmatic interventional design to test the efficacy and safety of adding multimodality TAT to standard of care systemic therapy in patients with limited mCRC....

Sex Differences in Characteristics, Resource Utilization, and Outcomes of Cardiogenic Shock: Data From the Critical Care Cardiology Trials Network (CCCTN) Registry.

Sex disparities exist in the management and outcomes of various cardiovascular diseases. However, little is known about sex differences in cardiogenic shock (CS). We sought to assess sex-related diffe... The Critical Care Cardiology Trials Network is a multicenter registry of advanced cardiac intensive care units (CICUs) in North America. Between 2018 and 2022, each center (N=35) contributed annual 2-... Of the 22 869 admissions in the overall population, 4505 (20%) had CS. Among 3923 patients with CS due to ventricular failure (32% female), 1235 (31%) had CS after acute myocardial infarction and 2688... Women with HF-CS had lower use of pulmonary artery catheters and mechanical circulatory support, shorter CICU lengths of stay, and higher in-hospital mortality than men, even after accounting for age,...

Arthroscopic Partial Meniscectomy for a Degenerative Meniscus Tear Is Not Cost Effective Compared With Placebo Surgery: An Economic Evaluation Based on the FIDELITY Trial Data.

In patients with a degenerative tear of the medial meniscus, recent meta-analyses and systematic reviews have shown no treatment benefit of arthroscopic partial meniscectomy (APM) over conservative tr... (1) Does APM result in lower postoperative costs compared with placebo surgery? (2) Is APM cost-effective compared with placebo surgery?... One hundred forty-six adults aged 35 to 65 years with knee symptoms consistent with a degenerative medial meniscus tear and no knee osteoarthritis according to the American College of Rheumatology cli... APM did not deliver lower postoperative costs, nor did it convincingly improve quality of life scores when compared with placebo surgery. From a societal perspective, APM was associated with € 971 (95... The results of this study lend further support to clinical practice guidelines recommending against the use of APM in patients with a degenerative meniscus tear. Given the robustness of existing evide...

Vaginal misoprostol versus vaginal dinoprostone for cervical ripening and induction of labour: An individual participant data meta-analysis of randomised controlled trials.

Induction of labour (IOL) is common practice and different methods carry different effectiveness and safety profiles.... To compare the effectiveness, and maternal and perinatal safety outcomes of IOL with vaginal misoprostol versus vaginal dinoprostone using individual participant data from randomised clinical trials.... The following databases were searched from inception to March 2023: CINAHL Plus, ClinicalTrials.gov, Cochrane Pregnancy and Childbirth Group Trial Register, Ovid Embase, Ovid Emcare, Ovid MEDLINE, Sco... Randomised controlled trials (RCTs), with viable singleton gestation, no language restrictions, and all published and unpublished data.... An individual participant data meta-analysis was carried out.... Ten of 52 eligible trials provided individual participant data, of which two were excluded after checking data integrity. The remaining eight trials compared low-dose vaginal misoprostol versus dinopr... Low-dose vaginal misoprostol and vaginal dinoprostone for IOL are comparable in terms of effectiveness and perinatal safety. However, low-dose vaginal misoprostol is likely to lead to a lower rate of ...

Are web-based stress management interventions effective as an indirect treatment for depression? An individual participant data meta-analysis of six randomised trials.

Depression is highly prevalent and associated with numerous adverse consequences for both individuals and society. Due to low uptake of direct treatment, interventions that target related, but less st... Bayesian one-stage models were used to estimate pooled effects on depressive symptom severity, minimally important improvement and reliable deterioration. The dose-response relationship was examined u... In total, N=1235 patients suffering from clinical-level depression from K=6 randomised trials were included. Moderate-to-large effects were found on depressive symptom severity at 7 weeks post-interve... Our results indicate that web-based stress management can serve as an indirect treatment, yielding effects comparable with direct interventions for depression. Further research is needed to determine ... Open material repository: osf.io/dbjc8, osf.io/3qtbe.... German Clinical Trial Registration (DRKS): DRKS00004749, DRKS00005112, DRKS00005384, DRKS00005687, DRKS00005699, DRKS00005990....

Effect of modernized collaborative care for depression on brain-derived neurotrophic factor (BDNF) and depressive symptom clusters: Data from the eIMPACT trial.

Brain-derived neurotrophic factor (BDNF) levels are lower in people with depression and are normalized following pharmacological treatment. However, it is unknown if psychological treatments for depre...

Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials.

Background Sodium glucose cotransporter-2 inhibitors reduce systolic blood pressure (SBP), but whether they affect SBP variability is unknown. There also remains uncertainty regarding the prognostic v...